Lyra Therapeutics
LYRA
LYRA
35 hedge funds and large institutions have $59.9M invested in Lyra Therapeutics in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
38% less capital invested
Capital invested by funds: $96M → $59.9M (-$36.1M)
Holders
35
Holding in Top 10
–
Calls
$38K
Puts
$2K
Top Buyers
| 1 | +$751K | |
| 2 | +$282K | |
| 3 | +$123K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$22.3K |
| 5 |
BAM
Belpointe Asset Management
Reno,
Nevada
|
+$11.6K |
Top Sellers
| 1 | -$1.11M | |
| 2 | -$98K | |
| 3 | -$95K | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$78.5K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$64K |